Genetic-Maternal Environmental Interaction during Pregnancy as a Risk Factor for Congenital Heart Disease (CHD)

Abstract

Congenital heart disease (CHD) remains a major cause of neonatal mortality, and its underlying causes are still undefined. Increasing evidence shows that CHD results from complex interactions between genetic factors in the fetus and environmental exposures from the mother during pregnancy. This review brings together findings from experimental models, human studies, and molecular research to look at how these interactions affect heart development. Important mechanisms include reduced developmental strength, threshold effects, and changes in gene expression due to environmental factors. The review also compares findings from animal experiments with the challenges of human studies, highlighting gaps in exposure assessment. By focusing on the combined impact of genetic and maternal environmental factors, this review stresses the need for a comprehensive risk assessment and points out future directions for improving prevention strategies and the relevance of research in congenital heart disease.

Introduction

Congenital Heart Disease (CHD) is one of the most common birth defects, affecting about 1% of newborns and contributing significantly to infant illness and mortality. Although many genetic abnormalities are linked to CHD, only a minority of cases are explained by genetic factors alone. Current research shows that CHD often results from a complex interaction between fetal genetic susceptibility and maternal environmental conditions.

Key maternal risk factors include diabetes, obesity, smoking, alcohol or drug exposure, infections, nutritional deficiencies, anemia, hypoxia, and environmental toxins. These factors can interfere with important stages of heart development, particularly when exposure occurs during early pregnancy.

A major mechanism linking maternal environment with fetal genetics is epigenetics. Environmental stressors can alter DNA methylation, histone modifications, and non-coding RNA without changing the DNA sequence itself. These changes can affect genes involved in heart development and help explain why people with similar genetic variants can develop different forms—or no form—of CHD.

Research using animal models, human epidemiological studies, and genomic analyses supports the importance of gene-environment interactions. However, current studies have limitations, including a focus on individual genes or environmental factors, uncertain timing of exposures, limited diversity in study populations, and difficulties applying animal findings directly to humans.

Key Findings

• CHD is primarily multifactorial, involving both genetic and environmental influences.
• Maternal health and environmental exposures can increase the effect of otherwise low-risk genetic variants.
• Epigenetic changes provide an important biological link between maternal conditions and fetal heart development.
• Gene-environment interactions help explain the variable severity and incomplete penetrance of CHD.
• Improving maternal health before and during pregnancy could help reduce CHD risk.
• Integrated genetic, environmental, and epigenetic information may improve prenatal risk assessment and prevention.

Future Research

Future studies should combine genetic, epigenetic, and environmental data through long-term research involving diverse populations. Better measurement of maternal exposures and identification of critical periods during pregnancy could improve risk prediction and enable earlier preventive interventions.

In short: CHD is not usually caused by genetics or the maternal environment alone. It often develops through their interaction, making maternal health, environmental risk reduction, and integrated genetic research essential for better prevention and care.

Conclusion

This review highlights the increasing awareness of Congenital Heart Disease as a condition shaped by the interaction between genetic factors and maternal environmental influences. Evidence from genetic, experimental, and epidemiological studies shows that isolated genetic or environmental factors rarely work alone in determining heart outcomes. Instead, their combination during key stages of embryonic development has the greatest impact on disease risk. By incorporating information about environmental risk factors, gene-environment interactions, and epigenetic regulation, this paper stresses the need for a more comprehensive approach in congenital heart disease research. This approach could improve early risk assessment, direct preventive strategies focused on maternal health, and guide future investigations to find modifiable factors that contribute to the disease burden. Ongoing study of these interactions will be crucial for turning scientific knowledge into real improvements in prenatal care and long-term outcomes for individuals affected by this condition.

References

[1] Vecoli C, Pulignani S, Foffa I, Andreassi MG. Genetic and epigenetic mechanisms linking maternal environmental exposures and congenital heart disease. Curr Genomics. 2014 Oct;15(5):390–399. [2] Choudhury TZ. Mechanisms underlying gene-environment interactions in congenital heart disease [dissertation]. Columbus (OH): The Ohio State University; 2024. ProQuest Dissertations & Theses. No. 31693896. [3] Kalisch-Smith JI, Ved N, Sparrow DB. Environmental risk factors for congenital heart disease. Cold Spring Harb Perspect Biol. 2020;12(3):a037234. [4] Moreau JLM, Kesteven S, Martin EMMA, Lau KS, Yam MX, O\'Reilly VC, et al. Gene–environment interaction impacts on heart development and embryo survival. Development. 2019;146(7):dev172957. [5] Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge. Circulation. 2007;115(23):2995–3014. [6] Blue GM, Kirk EP, Sholler GF, Harvey RP, Winlaw DS. Congenital heart disease: current knowledge about causes and inheritance. Med J Aust. 2012;197(3):155–159.

Copyright

Copyright © 2026 Prateeksha Anandan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.